Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes()

PURPOSE: Bacillus Calmette-Guérin (BCG)-treatment is an established treatment for bladder cancer, but its mechanisms of action are not fully understood. High-risk non-muscle invasive bladder-cancer (NMIBC)-patients failing to respond to BCG-treatment have worse prognosis than those undergoing immedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryk, Charlotta, Koskela, Lotta Renström, Thiel, Tomas, Wiklund, N. Peter, Steineck, Gunnar, Schumacher, Martin C., de Verdier, Petra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556773/
https://www.ncbi.nlm.nih.gov/pubmed/26298202
http://dx.doi.org/10.1016/j.redox.2015.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556773/
https://www.ncbi.nlm.nih.gov/pubmed/26298202
http://dx.doi.org/10.1016/j.redox.2015.08.008

Ejemplares similares